https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001
Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years.
0
fool:-8822215013997509729
0
https://seekingalpha.com/article/4669991-eli-lilly-q4-earnings-overvaluation-big-red-flag?source=feed_all_articles
Feb 13, 2024 - Eli Lilly has strong financial performance with steady revenue growth and profitability expansion. Find out why LLY stock is a Sell.
0
sa:3434934217123608505
0
https://seekingalpha.com/news/4066258-eli-lilly-partner-bioage-wins-170m-zepbound-combo-study?source=feed_sector_healthcare
Feb 13, 2024 - Biotech startup BioAge Labs raises $170M for Phase 2 trials for a combination therapy involving Eli Lilly's Zepbound and other weight loss drugs. Read more here.
0
sa:1256304221051756253
0
https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001
Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring.
0
fool:2994529553355192000
0
https://seekingalpha.com/news/4074979-the-1t-club-could-soon-have-its-first-non-tech-members-berkshire-hathaway-eli-lilly?source=feed_sector_healthcare
Mar 02, 2024 - Berkshire Hathaway (BRK.A) (BRK.B) & Eli Lilly (LLY) could become the first non-tech companies to hit $1T in market cap. Read more here.
0
sa:9091267631812994021
0
https://www.fool.com/investing/2024/03/09/missed-out-on-eli-lilly-novo-nordisk-this-could/?source=iedfolrf0000001
Mar 09, 2024 - Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
0
fool:2477994999907167687
0
https://www.wired.com/story/elie-hassenfeld-givewell-ea/
Mar 27, 2024 - As Sam Bankman-Fried’s downfall sends effective altruism into a spiral of self-doubt, the idealist quant Elie Hassenfeld is still helping Silicon Valley richies give away hundreds of millions each year.
0
wr:7669777789359969872
0
https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?source=feed_sector_healthcare
Mar 30, 2024 - The Health Care Select Sector SPDR Fund ETF (XLV) lagged slightly behind the S&P 500 index in Q1 2024, rising 8.31% compared to the overall market's 10.04%...
0
sa:-139188292022679796
0
https://seekingalpha.com/news/4088326-eli-lilly-eyes-25b-plant-make-obesity-drugs?source=feed_sector_healthcare
Apr 09, 2024 - Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for its weight loss therapy tirzepatide. Read more here.
0
sa:7859183939841024881
0
https://seekingalpha.com/news/4090270-eli-lilly-subsidiary-precision-biosciences-end-gene-therapy-collaboration?source=feed_sector_healthcare
Apr 16, 2024 - Precision BioSciences (DTIL) said Eli Lilly (LLY) subsidiary Prevail Therapeutics has decided to conclude their gene therapy collaboration. Read more here.
0
sa:5291771516353797149
0